Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 26,898,200 | 23,636,900 | 19,828,700 | 16,681,100 | 14,969,800 |
| Cost of Goods | 13,925,400 | 11,790,300 | 9,319,200 | 7,456,300 | 5,962,700 |
| Gross Profit | 12,972,800 | 11,846,600 | 10,509,500 | 9,224,800 | 9,007,100 |
| Operating Expenses | 6,332,900 | 6,325,900 | 5,569,600 | 4,629,500 | 4,908,400 |
| Operating Income | 6,640,299 | 5,521,000 | 4,940,100 | 4,595,600 | 4,099,399 |
| Other Income | 1,492,801 | 941,300 | 600,700 | 201,600 | 315,801 |
| Pre-tax Income | 8,133,100 | 6,462,300 | 5,540,800 | 4,797,200 | 4,415,200 |
| Income Tax | 2,884,900 | 1,848,200 | 1,659,500 | 1,462,000 | 1,418,200 |
| Net Income Continuous | 5,248,200 | 4,614,100 | 3,881,300 | 3,335,200 | 2,997,000 |
| Net Income | $5,248,200 | $4,614,100 | $3,881,300 | $3,335,200 | $2,997,000 |
| EPS Basic Total Ops | 2.21 | 1.92 | 1.60 | 1.35 | 1.19 |
| EPS Basic Continuous Ops | 2.21 | 1.92 | 1.60 | 1.35 | 1.19 |
| EPS Diluted Total Ops | 2.15 | 1.87 | 1.60 | 1.35 | 1.19 |
| EPS Diluted Continuous Ops | 2.21 | 1.87 | 1.60 | 1.35 | 1.19 |
| EBITDA(a) | $7,655,399 | $6,358,100 | $5,671,000 | $5,262,800 | $4,781,000 |